029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
DLV551肝癌（临床分期以IV期为主）及肝组织组合芯片（WHO+2010版），附病理分级、TNM和临床分期（参考AJCC第七版分期），55例/55点
点 数55例 数55
行 数6列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:DLV551
 
肝癌及肝组织组合微阵列芯片，包含40例肝内胆管细胞癌，10例混合癌，5例肝组织，一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Liv
-Liver
 
Malignant (IVA)
 
Normal (*)
TISSUE  ARRAYS DLV551
1
2
3
4
5
6
7
8
9
10
A
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
B
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
C
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
D
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
E
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
F
LIV
LIV
LIV
LIV
LIV
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1168MLiverIntrahepatic cholangiocarcinoma1T3N1M0IVAMalignantN
A2247MLiverIntrahepatic cholangiocarcinoma1T3N1M0IVAMalignantN
A3367MLiverIntrahepatic cholangiocarcinoma1--2T2N1M0IVAMalignantN
A4450FLiverIntrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
A5554MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
A6652FLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
A7762FLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
A8871MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
A9956MLiverIntrahepatic cholangiocarcinoma2T4N1M0IVAMalignantN
A101049MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
B11149MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
B21246MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
B31342MLiverIntrahepatic cholangiocarcinoma2T4N1M0IVAMalignantN
B41451MLiverIntrahepatic cholangiocarcinoma2T4N1M0IVAMalignantN
B51568MLiverIntrahepatic cholangiocarcinoma2T4N1M0IVAMalignantN
B61646FLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
B71769FLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
B81860MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
B91964MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
B102063MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
C12173MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
C22265MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
C32355FLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
C42442MLiverIntrahepatic cholangiocarcinoma2T1N1M0IVAMalignantN
C52555MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
C62677MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
C72762FLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
C82858MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
C92939FLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
C10300MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
D13166MLiverIntrahepatic cholangiocarcinoma2T3N1M0IVAMalignantN
D23268MLiverIntrahepatic cholangiocarcinoma3T3N1M0IVAMalignantN
D33367MLiverIntrahepatic cholangiocarcinoma3T3N1M0IVAMalignantN
D43447FLiverIntrahepatic cholangiocarcinoma*T2N1M0IVAMalignantN
D53540MLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
D63645MLiverIntrahepatic cholangiocarcinoma3T3N1M0IVAMalignantN
D73770FLiverIntrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
D83846MLiverIntrahepatic cholangiocarcinoma3T1N1M0IVAMalignantN
D93958FLiverIntrahepatic cholangiocarcinoma3T1N1M0IVAMalignantN
D104058MLiverIntrahepatic cholangiocarcinoma3T4N1M0IVAMalignantN
E14156MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
E24252FLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
E34364MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T2N1M0IVAMalignantN
E44440MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
E54552FLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3N1M0IVAMalignantN
E64666MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T2N1M0IVAMalignantN
E74757MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3aN1M0IVAMalignantN
E84867FLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T3aN1M0IVAMalignantN
E94961FLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T2N1M0IVAMalignantN
E105063MLiverMixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma*T2N1M0IVAMalignantN
F15138MLiverLiver tissue***NormalN
F25240MLiverLiver tissue***NormalN
F35335MLiverLiver tissue***NormalN
F45416MLiverLiver tissue***NormalN
F55535FLiverLiver tissue***NormalN
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情